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EPIDERMAL SENSITIZATION TO BUTESIN. AN EXPERIMENTAL
STUDY ON THE RANGE OF SPECIFICITY*t
EDWARD L. LADEN, M.D., AND LOUIS RUBIN, M.D.
Observation of a patient with an eczematous dermatitis resulting from the
application of butesin picrate ointment provided an opportunity to determine
the range of specificity of this allergic reaction.
The patient was a 15 year old boy who had suffered a first degree burn of his
left forearm. "Butesin picrate" ointment was applied for about five days.
Approximately one week later an itching, vesicular eruption of the skin in this
area developed. At this time, the boy came under our observation. No history
of previous cutaneous contact with butesin picrate or any other local anesthetic
agent could be elicited.
The dermatitis subsided rapidly with routine local treatment. After complete
involution, patch tests with the commercial ointment which contains 1%
butesin picrate and with a 2% solution of butesin in triethanolamine were
applied to the skin of the back. Strongly positive reactions with redness,
edema and vesiculation were noted after 24 hours at both test sites.
Patch tests were then carried out with a series of related compounds. These
were dissolved in triethanolamine in 2% concentrations and applied as routine
patch tests. Although the patient's sensitivity was of a high degree as deter-
mined by later quantitative testing, he failed to react if the material was merely
dropped on the skin and wiped off after 5 minutes. This latter method was
described previously in testing a similar case (1).
Butesin is the n-butyl ester of p-aminobenzoic acid. This compound and a
series of homologous p-aminobenzoic acid alkyl esters including the methyl,
ethyl, n-propyl, isopropyl, isobutyl and amyl esters elicited strongly positive
patch test reactions. Para-aminobenzoic acid and each of the alcohols which
form these esters, when tested separately elicited negative reactions.
In order to determine whether the para position of the aromatic amino group
was essential for the reaction, the methyl ester of meta-aminobensoic acid was
synthesized. This substance failed to elicit a reaction.
The next step was to determine whether other local anesthetics containing a
benzene ring but otherwise differing in their steric configuration from the alkyl
esters were capable of eliciting reactions. We first tested procaine and related
members which are also esters of p-aminobenzoic acid but differ from the alkyl
esters in that they contain secondary or tertiary amines in the side chain. These
were procaine, butyn, larocaine, pontocaine, monocaine and tutocaine*. All
failed to elicit a reaction.
* From the Division of Dermatology, Department of Medicine, University of Chicago,
Chicago, Ill.
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The next group to be tested were anesthetics with tertiary amines in their
side chain but without the aromatic amino group on the benzene ring. These
FIG. 1. PATCI-I TESTS WITH VARYING DILIJTIONS OF THE METHYL ESTER AND
fl-BIJPYL ESTEE OF p-AMJNOBENZOIC ACID
A methyl ester, (1) 1:10, (2) 1:10, (3) 1:10
B n-butyl ester, (1) 1:10, (2) 1:10, (3) 1:102
TABLE I
Effective threshold concentrations of p-aminobenzoic acid alkyl esters
ESTEE EffECTIVE THRESHOLD
CONCENTRATIONS
Methyl 1:102
Ethyl ("benzocaine") 1:106
Propyl 1:10
Butyl ("butesin") 1:106
Amyl 1:106
1:106Isopropyl
Isobutyl 1: 10
were alypin, metycaine, stovaine, nupercaine, diothane, phenacaine, apothesine
and intracaine.' These too failed to elicit any reactions.
Subsequently, the seven alkyl esters which elicited positive reactions were
tested quantitatively to determine threshold concentrations at which a just
1 For the chemical formulae of these compounds see (Ref. 1).
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perceptible inflammatory reaction occurred. The result of one such experiment
with the methyl and n-butyl esters is shown in Figure 1.
Table I reveals that the sensitivity to the methyl ester was relatively low.
With increasing length of the side chain, the sensitivity increased to reach a
maximum with the propyl ester. Further lengthening resulted in decreased
sensitivity. In both cases, the iso-compounds produced considerably less
reaction than their isomer n-compounds. It is interesting that the propyl ester
with which no apparent previous contact had occurred was associated with a
higher degree of sensitivity than was the butyl ester.
DISCTJSSION
Since it has become apparent that the human skin is capable of developing
reactions of hypersensitivity to relatively simple, non-protein chemical com-
pounds, a considerable amount of work has been done to elucidate the mechanism
of such sensitization and its range of specificity. Two main approaches have
been followed, first by deliberate sensitization of animal and human subjects and
secondly by studying spontaneous or "naturally" occurring hypersensitivities
in man.
Deliberate sensitization of guinea pigs to nitro and chioro substituted benzenes
was carried out by Landsteiner and Jacobs (2, 3). These authors demonstrated
that those compounds in which the chioro and nitro groups were more labile, as
demonstrated by their susceptibility to decomposition by alkalis and their strong
capacity for entering into combination with anilin, were strong sensitizers of
guinea pig skin. Less labile nitro and chioro substituted benzenes failed to
sensitize guinea pig skin. In these experiments, sensitization was done by
intradermal injections. Later Sulzberger and Baer (4) used some of these
nitro and ehlovo substituted benzenes to show that the same applied for human
skin. Sensitization was carried out by the dropping of the material on intact
skin as well as by intradermal injection.
Sehwarzchild (5) artificially sensitized human subjects to various local an-
esthetic agents including orthoform, the methyl ester of p-amino metaoxybenzoic
acid, and anesthesin, the ethyl ester of p-aminobenzoic acid ("benzocaine").
He then studied the range of specificity of these sensitivities and found that
subjects who were sensitized to the ethyl ester of p-aminobenzoic acid exhibited
equally strong reactions to the propyl ester and isobutyl ester. One subject was
tested with the methyl ester and developed a weakly positive reaction.
More recently Rostenberg and Kanof (6) have studied subjects in whom
they produced an eczematous type of sensitivity to 2:4 dinitrochlorobenzene.
They concluded that in such individuals positive reactions may be obtained
with compounds which are related to the original sensitizing substance ill) a
stereochemical resemtiance exists between the new compound and the sensitizing
substance and 2) the new compound is capable of forming conjugates which are
similar to those formed by the original substance.
The second approach to the problem has been the study of patients who were
observed for an eczematous dermatitis resulting from cOntact with a chemical
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agent either through occupational exposure or for therapeutic purposes. The
agent in practically all of the cases reported has been a local anesthetic and
principally procaine. Such patients have been tested with chemicals whose
structures varied in certain important particulars from that of the original
sensitizer to determine the range of specificity and correlate hypersensitivity to
chemical structure. The fact that the majority of the agents tested were local
anesthetics tended to complicate the problem since, as pointed out by Rostenberg,
one cannot be sure whether related hypersensitivities were not due to previous
contact of the patient with the agents tested. This also might help explain
some of the contradictory results that were reported by some of the investigators.
Mook (7) in 1920 was the first to report dermatitis resulting from contact
with a local anesthetic, the agent being apothesine. In 1921, C. G. Lane (8)
reported 3 cases of dermatitis resulting from contact with procaine. Lane
tested one subject to apothesine and cocaine as well as procaine and obtained
positive reactions only with procaine. Greenwood and Guest (9) in 1924
reported a case of butyn dermatitis. Their patient gave positive reactions to
butyn and procaine. Tests with other local anesthetics were not done. Bart M.
James (10) in 1931 and G. W. Waidron (11) in 1934 each studied patients with
procaine dermatitis but were unable to establish any relationship between
chemical structure and the substances capable of causing a reaction. James'
patient reacted to procaine but not to borocaine which is the borate salt of
procaine. Reactions occurred to alypin and to butesin both of which have
significant structural variation from procaine. The patient also reacted to
vuzin, a totally unrelated anesthetic of the quinoline group.
M. H. Goodman (12) in 1939 studied another patient with procaine hyper-
sensitivity. This patient exhibited strong reactions to procaine, larocaine,
butyn, pontocaine, tutocaine and borocaine. These substances bear close
resemblance to one another in that they are all esters of para-aminobenzoic
acid with a secondary or tertiary amine in the side chain. Compounds with the
amino group in the meta or ortho position gave negative reactions. No reaction
occurred to alypin, a benzoic acid ester with a tertiary amine in the side chain,
but without an aromatic amino group. The patient also reacted, but to a lesser
degree, to butesin and other alkyl esters of para-aminobenzoic acid as well as to
para-aminobenzoic acid itself. Consistently negative reactions occurred to
compounds of a benzene ring structure in which the amino group and carboxyl
group were other than in the position to constitute the structural base para-
aminobenzoic acid. However, this patient reacted to phenol and phenol
compounds, thus indicating a multiple sensitivity.
Rothman, Orland and Flesch (1) studied 2 dentists with procaine dermatitis
and found in each a sensitivity which was specific only for members of the
procaine group, namely procaine, larocaine, butyn, pontocaine, tutocaine and
monocaine. All p-aminobenzoic acid esters with a tertiary amine in the side
chain but without an aromatic amino group, or with an amino group in the
meta or ortho position did not cause reactions. Simple straight chain alkyl
esters of p-aminobenzoic acid and p-aminobenzoic acid itself were also ineffective.
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Most recently, Strauss (13) has reported 2 cases of sensitivity to local an-
esthetics, one of which reacted in a manner identical to that of the 2 patients
of Rothman et al. The other patient reacted only to two compounds, pontocaine
and apothesine, anesthetics which differ significantly from one another in their
chemical structure. No reactions occurred to agents which are closely related to
either pontocaine or apothesine.
Sulzberger and Wise (14) in 1033 reported 4 cases of eczematous dermatitis
caused by the application of butesin picrate ointment. In all of their cases as in
ours, dermatitis did not appear until 7—13 days after the discontinuance of the
medicament. One of the 4 patients was patch tested with the related compound,
ethyl aminobenzoate, and yielded a positive reaction. No other attempts were
made to determine group sensitivity.
The only other study of group sensitivity to the alkyl esters of p-aminobenzoic
acid that we were able to find was that of Schwarzschild who deliberately
sensitized individuals to local anesthetics. Four subjects were sensitized to the
ethyl ester of p-aminobenzoic and also gave positive reactions with the isobutyl
ester and with the propyl ester of p-aminobenzoic acid. One of these patients
was also tested with the methyl ester of p-aminobenzoic acid and responded
with a very weak reaction.
Studies such as the one we have carried out have been criticized by Rostenberg
because of the difficulty of proving whether the individuals tested had not been
previously exposed to the related substances, and also because one cannot prove
that the subjects are not highly reactive (multiple sensitivities). We feel that
such an objection will become invalid if a sufficiently large number of subjects
are studied and a consistent pattern of reaction is determined. Actually so far
only a small number of cases has been studied. In one group, contact dermatitis
could be induced in a rather haphazard fashion by a number of not closely
related compounds, a phenomenon which seems to justify Rostenberg's objections
to such studies. In the other group, however, the sensitivity had a rather narrow
range within a well defined chemical configuration. Such sensitivity patterns
have been perfectly identical in different persons and therefore may be regarded
as essential in the mechanism of sensitization. Thus, the two cases of Rothman
et al. and the one case of Strauss all show exactly the same range of specificity.
Our patient reacted in a manner identical to that of the 4 subjects sensitized by
Schwarzschild. Therefore, there is good reason to believe that if more cases are
studied such patterns of reaction will be determined a significant number of
times.
A remarkable feature which has been encountered in these group sensitivities
is that the maximum sensitivity occurs not with the actually sensitizing com-
pound but with one of the related homologues. Thus, in the case of Rothman
et al. the patient was more sensitive to butyn sulfate than to procaine, the
apparent sensitizer. Since butyn sulfate is a commercially used anesthetic
agent, one cannot be sure that contact with it had not occurred previously.
However, in our patient where the sensitivity was one hundred times greater
to the propyl ester than to the original sensitizer, the butyl ester, previous
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contact with the former seems most unlikely. We were unable to find any
evidence that the propyl ester is used as a pharmaceutical agent and it obviously
is not encountered in everyday life. The sample that we used was synthesized
for us in the Pharmacology Department of the University of Chicago. Under
these circumstances it seems reasonable to assume that to whatever p-amino-
benzoic acid alkyl ester the sensitization occurs, the strongest reaction would be
obtained with the propyl ester.
Schwartzschild claimed that individuals sensitized to the ethyl ester of p-
aminobenzoic acid exhibited equally strong reactions to the propyl ester and
isobutyl ester. However, he did not make quantitative studies of the degree of
sensitivity by determining the threshold concentration at which the reactions
first occurred. Sufficiently high concentrations would provoke equally strongly
positive reactions with each agent. From Schwartzschild's data, it is impossible
to state as to which agent was associated with the maximum degree of sensitivity
in his cases.
Schwartzschild reported that the methyl ester produced a weakly positive
eaction as compared with the other esters. Our determination of effective
rhreshold concentrations also showed the methyl ester to be associated with the
towest degree of sensitivity.
SUMMARY
In the case reported, epidermal hypersensitivity was limited to the alkyl
esters of p-aminobenzoic acid. Benzoic acid esters which deviated from this
basic structure either in the ring or in the side chain did not elicit reactions.
These findings are in agreement with the results of a previous experimental
study and it seems that the pattern of specificity presented here is a significant
feature of butesin hypersensitivity.
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